thiophenes has been researched along with Lymphoma in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (23.08) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Fukuoka, N; Harada, M; Kataoka, T; Nakao, A; Nghia, VT; Nishida, A; Tanigaki, R | 1 |
Arunan, V; Beloueche-Babari, M; Casals Galobart, T; Chung, YL; Eykyn, TR; Koniordou, M; Leach, MO; Parkes, HG; Smith, PD; Wantuch, S | 1 |
Brennan, MS; Chang, C; Dewson, G; Herold, MJ; Kelly, GL; Lessene, G; Strasser, A; Tai, L | 1 |
Deng, C; Jaken, S; Lipstein, M; McIntosh, C; O'Connor, OA; Rodriguez, R; Serrano, XO; Tsai, WY; Wasmuth, AS | 1 |
Aubrey, BJ; Balint, B; Blasko, G; Brennan, MS; Bruno, A; Cauquil, N; Chang, C; Chanrion, M; Chen, I; Colland, F; Csekei, M; Davidson, J; Dokurno, P; Galbraith, LC; Geneste, O; Girard, AM; Gong, JN; Graham, C; Gravé, F; Guasconi, G; Guigal-Stephan, N; Herold, MJ; Hickman, JA; Huang, DC; Kelly, GL; Kotschy, A; Le Toumelin-Braizat, G; Lessene, G; Lockhart, B; Lysiak-Auvity, G; Maragno, AL; Matassova, N; Melchiore, F; Moujalled, DM; Murray, J; Ondi, L; Paczal, A; Pedder, C; Pomilio, G; Proszenyak, A; Radics, G; Riffkin, CD; Roberts, AW; Robertson, A; Segal, D; Sipos, S; Smith, J; Strasser, A; Studeny, A; Surgenor, A; Szabo, ZB; Szlavik, Z; Wei, AH | 1 |
Forshell, LP; Höglund, A; Li, Y; Nilsson, JA; Strömvall, K | 1 |
Kelloff, G; Rao, CV; Reddy, BS; Rivenson, A; Steele, V; Zang, E | 1 |
Begleiter, A; Curphey, TJ; Leith, MK | 1 |
Kensler, TW; Roebuck, BD; Rogers, AE | 1 |
Bertucci, D; Goh, BC; Mani, S; Ratain, MJ; Vogelzang, NJ; Vokes, EE | 1 |
Blanton, CD; Koebel, RF; Needham, LL | 1 |
De Blasi, A; Fratelli, M; Marasco, O | 1 |
Dombernowsky, P; Larsen, V; Nissen, NI | 1 |
1 trial(s) available for thiophenes and Lymphoma
Article | Year |
---|---|
A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Quinazolines; Thiophenes | 1999 |
12 other study(ies) available for thiophenes and Lymphoma
Article | Year |
---|---|
Eomesodermin promotes interaction of RelA and NFATc2 with the Ifng promoter and multiple conserved noncoding sequences across the Ifng locus in mouse lymphoma BW5147 cells.
Topics: Amides; Animals; Cell Line, Tumor; Conserved Sequence; Gene Expression Regulation, Neoplastic; Genetic Loci; Interferon-gamma; Lymphoma; Mice; NFATC Transcription Factors; Promoter Regions, Genetic; Protein Kinase Inhibitors; STAT3 Transcription Factor; T-Box Domain Proteins; Thiophenes; Transcription Factor RelA | 2020 |
MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.
Topics: Acrylates; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tumor; Energy Metabolism; Female; HT29 Cells; Humans; Lactic Acid; Lymphoma; Magnetic Resonance Spectroscopy; Metformin; Mice, SCID; Mitochondria; Monocarboxylic Acid Transporters; Muscle Proteins; Pyrimidinones; Symporters; Thiophenes; Xenograft Model Antitumor Assays | 2017 |
Humanized
Topics: Alleles; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; Humans; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cell Leukemia Sequence 1 Protein; Pyrimidines; Thiophenes | 2018 |
The novel IKK2 inhibitor LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB.
Topics: Animals; Apoptosis; Cell Line, Tumor; Drug Synergism; Flow Cytometry; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; I-kappa B Kinase; Lymphoma; Mice; NF-kappa B; Pyrimidines; Signal Transduction; Thiophenes | 2015 |
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Female; Humans; Leukemia; Lymphoma; Male; Mice; Models, Biological; Models, Molecular; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Pyrimidines; Thiophenes; Xenograft Model Antitumor Assays | 2016 |
Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.
Topics: Animals; Apoptosis; Cell Line; Checkpoint Kinase 2; DNA Damage; Fluorescent Antibody Technique; Humans; Lentivirus; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; NIH 3T3 Cells; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Thiophenes; Transfection; Urea | 2011 |
Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Imidazoles; Intestinal Neoplasms; Lymphoma; Male; Pyrazines; Rats; Rats, Inbred F344; Thiones; Thiophenes | 1996 |
Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents.
Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Enzyme Induction; Indolequinones; Indoles; Lymphoma; Mice; Mice, Inbred DBA; Mitomycin; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Thiones; Thiophenes; Tumor Cells, Cultured | 1996 |
Correspondence re: C.V. Rao, et al., Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced lymphoma formation by oltipraz. Cancer Res., 56: 3395-3398, 1996.
Topics: Aflatoxin B1; Animals; Anticarcinogenic Agents; Hematologic Neoplasms; Imidazoles; Lymphoma; Male; Pyrazines; Rats; Rats, Inbred F344; Thiones; Thiophenes | 1997 |
Synthesis of thieno[2,3-b]azepin-4-ones as potential antineoplastic agents.
Topics: Animals; Antineoplastic Agents; Azepines; Leukemia L1210; Lymphoma; Melanoma; Mice; Neoplasms, Experimental; Thiophenes | 1975 |
Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol.
Topics: Adrenergic beta-Antagonists; Binding, Competitive; Humans; Leukocytes, Mononuclear; Lymphoma; Male; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Stereoisomerism; Sympathomimetics; Thiophenes; Tumor Cells, Cultured | 1988 |
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Female; Glycosides; Haplorhini; Hodgkin Disease; Humans; Immunosuppression Therapy; Lactones; Lymphoma; Male; Mice; Middle Aged; Neoplasms; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Thiophenes | 1972 |